Lower Risk of Incident Dementia with SGLT2 Inhibitor Versus DPP-4 Inhibitor Initiation in Patients with Type 2 Diabetes and Prior Traumatic Brain Injury: A Retrospective Cohort Study.

Overview

1. Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan
2. School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan
3. Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan
4. Department of Anesthesiology, Chi Mei Hospital, Liouying, Tainan, Taiwan

Abstract

Purpose: SGLT2 inhibitors have been associated with reduced dementia risk in patients with type 2 diabetes mellitus (T2DM); however, whether this association extends to patients with traumatic brain injury (TBI) remains unknown.

Patients and Methods: We conducted a new-user, active-comparator, retrospective cohort study using the TriNetX Research Network. Adults aged ≥50 years with T2DM and a history of TBI who newly initiated an SGLT2 inhibitor were compared with new users of a DPP-4 inhibitor as the active-comparator group between 2014 and 2023. A 1-year landmark period was applied before the outcome was ascertained. The primary outcome was incident dementia during an analytic window extending from day 365 to up to 10 years after the index date. Secondary outcomes included dementia subtypes (ie, vascular dementia or Alzheimer’s disease) and all-cause mortality. Propensity score matching, sensitivity analyses, and multivariable Cox regression were performed.

Results: After matching, 3,877 patients were included in each group. Incident dementia occurred in 129 patients (3.33%) in the SGLT2 inhibitor group and 243 patients (6.27%) in the DPP-4 inhibitor group (HR, 0.71; 95% CI, 0.57–0.88; p = 0.002). In exploratory secondary analyses, associations were observed for vascular dementia (HR, 0.49; p = 0.005) and all-cause mortality (HR, 0.76; p < 0.001), but not for Alzheimer’s disease (HR, 0.90; p = 0.654). A similar exploratory association was observed in the code-defined non-concussion intracranial injury subgroup (HR, 0.65; p = 0.004).

Conclusion: In this retrospective cohort study, SGLT2 inhibitor use was associated with a lower risk of incident dementia in patients with T2DM and TBI. These hypothesis-generating findings warrant further prospective validation.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

• 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
• 0 scripts, each with its path and the digest of its content;
• no match between paragraphs and code yet;
• neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data Sharing Statement

The data utilized in this study were obtained from the TriNetX Research Network under a collaborative agreement and are not publicly available. De-identified data may be made available upon reasonable request to the corresponding author, pending approval from TriNetX and compliance with the required data-sharing agreement or network membership.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 3 authors, 5 keywords, 13 MeSH terms, 1 funder, 36 references.

Cite

This paper

Hung, K.-C., Weng, H.-L., & Chen, I.-W. (2026). Lower Risk of Incident Dementia with SGLT2 Inhibitor Versus DPP-4 Inhibitor Initiation in Patients with Type 2 Diabetes and Prior Traumatic Brain Injury: A Retrospective Cohort Study. Drug design, development and therapy, 20, 624727. https://doi.org/10.2147/dddt.s624727

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41598-026-53148-5

Neurovascular and inflammatory effects of biperiden in the acute phase of moderate traumatic brain injury: evidence from a non-human primate model.

Journal: Scientific reports

In common: traumatic brain injury, other, 1 reference

[2] doi:10.1186/s40478-026-02240-y

GFAP degradation in TBI: linking novel modified products to astrocyte pathology and patient outcome.

Journal: Acta neuropathologica communications

In common: traumatic brain injury, other, 1 reference

[3] doi:10.1186/s13195-026-02110-8

Cognitive, biomarker, and neuroimaging indices associated with traumatic encephalopathy syndrome across two independent athlete cohorts.

Journal: Alzheimer's research & therapy

In common: traumatic brain injury, other, Alzheimer's / dementia, 2 other categories

[4] doi:10.1371/journal.pone.0345651 [code]

Non-concussive head impacts sustained during American football correlate with changes in gut microbiome diversity and composition.

Journal: PloS one

In common: traumatic brain injury, clinical / translational, 1 reference

[5] doi:10.1126/sciadv.aed8653

Targeting astrocytic Dp71 attenuates BBB disruption after traumatic brain injury through WTAP-associated m&lt;sup&gt;6&lt;/sup&gt;A regulation of MMP2.

Journal: Science advances

In common: traumatic brain injury, 1 reference

[6] doi:10.1002/alz.71471 [code]

How does type 2 diabetes modify the risk of Alzheimer's disease?

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

In common: Alzheimer's / dementia, other condition, 1 reference

[7] doi:10.1186/s13195-026-02086-5

Examining the additive risk of TBI and comorbid conditions on dementia in military veterans: a retrospective cohort study.

Journal: Alzheimer's research & therapy

In common: traumatic brain injury, other, Alzheimer's / dementia, 1 other category

[8] doi:10.1038/s41598-026-47942-4 [code]

CT-based radiomic markers to predict late-onset seizures after traumatic brain injury.

Journal: Scientific reports

In common: traumatic brain injury, other, clinical / translational, 1 other category

[9] doi:10.1038/s41467-026-73036-w [code]

Single-nucleus analysis reveals human-specific oligodendrocyte polarization and conserved neuronal responses after severe traumatic brain injury.

Journal: Nature communications

In common: traumatic brain injury, 1 reference

[10] doi:10.3389/fneur.2026.1822479 [code]

Circulating neuron-derived cfDNA for blood-based detection of Alzheimer's and other neurodegenerative conditions.

Journal: Frontiers in neurology

In common: other, Alzheimer's / dementia, clinical / translational, 1 other category

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.